• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A preliminary study of the effect of 11a-hydroxyprogesterone on the hair growth in men suffering from androgenetic alopecia.

作者信息

van der Willigen A H, Peereboom-Wynia J D, van Joost T, Stolz E

出版信息

Acta Derm Venereol. 1987;67(1):82-5.

PMID:2436423
Abstract

Ten male patients suffering from androgenetic alopecia were treated during one year with a lotion containing 1% 11a-hydroxyprogesterone. Eight untreated patients served as control group. The parameters used were hair root status, hair shaft diameter of anagen hair roots and number of hairs with a diameter less than 40 micron. After therapy the cranial region showed an increase in the number and mean hair shaft diameter of anagen hair roots and in the number of hair roots with a diameter less than 40 micron. The number of hair roots in catagen/telogen decreased, the number of dysplastic/dystrophic hair roots remained unchanged. After therapy the cranial region in the controls showed a decrease in number and mean hair shaft diameter of anagen roots, and in the number of dysplastic/dystrophic hair roots. There was an increase in number of hair roots in catagen/telogen and of hair roots with a diameter less than 40 micron. The results warrant the conclusion that the above mentioned therapy would seem to be effective in men suffering from androgenetic alopecia.

摘要

相似文献

1
A preliminary study of the effect of 11a-hydroxyprogesterone on the hair growth in men suffering from androgenetic alopecia.
Acta Derm Venereol. 1987;67(1):82-5.
2
The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females.
Acta Derm Venereol. 1989;69(5):395-8.
3
[Changes in telogen rate, hair density, hair diameter and rate of growth in androgenetic alopecia of the male. Simultaneously a contribution to the significance of dysplastic hair].[男性雄激素性秃发中休止期毛发比率、毛发密度、毛发直径及生长速率的变化。同时探讨发育异常毛发的意义]
Hautarzt. 1986 Apr;37(4):198-204.
4
Hair root studies in patients suffering from primary and secondary syphilis.原发性和继发性梅毒患者的发根研究。
Acta Derm Venereol. 1987;67(3):250-4.
5
A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.一项随机、双盲、安慰剂对照的初步研究,旨在评估用 0.1%拉坦前列素进行为期 24 周的局部治疗对雄激素性脱发的健康志愿者的毛发生长和色素沉着的疗效。
J Am Acad Dermatol. 2012 May;66(5):794-800. doi: 10.1016/j.jaad.2011.05.026. Epub 2011 Aug 27.
6
'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.细胞毒性药物所致的“萎缩性休止期脱发”以及一项关于研究局部应用维生素D类似物预处理对人类可能的保护作用的随机对照试验。
Br J Dermatol. 2005 Jul;153(1):103-12. doi: 10.1111/j.1365-2133.2005.06608.x.
7
[Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study (author's transl)].17α-雌二醇治疗雄激素性脱发的局部疗法。一项对照、随机双盲研究(作者译)
Dermatologica. 1980;161(2):124-32.
8
Topical minoxidil therapy for androgenetic alopecia. A 30-month study.外用米诺地尔治疗雄激素性脱发。一项为期30个月的研究。
Arch Dermatol. 1987 Nov;123(11):1483-7.
9
Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials.使用富集细胞培养基治疗雄激素性脱发的新型疗法的初步研究:临床试验
Dermatol Online J. 2003 Feb;9(1):4.
10
Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.非那雄胺(每日1毫克)治疗雄激素性脱发男性的毛发重量变化:3年和4年结果
J Am Acad Dermatol. 2006 Jul;55(1):71-4. doi: 10.1016/j.jaad.2005.07.001. Epub 2006 May 3.

引用本文的文献

1
Functional characterization and unraveling the structural determinants of novel steroid hydroxylase CYP154C7 from sp. PAMC26508.来自sp. PAMC26508的新型甾体羟化酶CYP154C7的功能表征及结构决定因素解析
Heliyon. 2024 Oct 24;10(21):e39777. doi: 10.1016/j.heliyon.2024.e39777. eCollection 2024 Nov 15.